← Open Payments lookup

ARIF SHOAIB: Open Payments

NPI 1407838394 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,207 in 71 payments from 17 companies in 2025. Trend: 2023 $1,793 · 2024 $2,081 · 2025 $2,207

Food & beverage: $2,207
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.12$461
Otsuka America Pharmaceutical, Inc.13$410
Axsome Therapeutics, Inc.10$387
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$284
Teva Pharmaceuticals USA, Inc.1$123
ABBVIE INC.5$112
Noven Therapeutics, LLC4$83
Vanda Pharmaceuticals Inc.3$63
Lundbeck LLC2$48
Janssen Pharmaceuticals, Inc2$44

Products named: COBENFY, Auvelity, CAPLYTA, ABILIFY MAINTENA, REXULTI, UZEDY, VRAYLAR, Xelstrym.

Industry payments across TX — which companies pay providers there.